Rapid Response Research Award Recipient: Dhakrit (Jesse) Rungkitwattanakul, PharmD, BCPS,

Jesse Headshot

Characteristics and outcomes of HIV-infected patients with COVID-19.

June 22, 2020

As of May 15, the number of confirmed worldwide cases of coronavirus disease 2019 (COVID-19) has exceeded four million cases with more than 300,000 deaths. Several reports showed the presence of organ impairments including lung and kidney damage are linked to the worsening death rates. Disease states such as high blood sugar, high blood pressure, advanced age, and male gender have been shown as risk factors. Surprisingly, human immunodeficiency virus (HIV) infection has not been linked as a risk factor or death. A recent report from New York City, an epicenter for both HIV infection and SARS-CoV-2, showed only 0.8% of HIV-infected patients with COVID-19represented in the study. The underrepresentation of PLWH from previous reports is concerning. We have little to no information on this finding on how HIV patients would react to COVID19. In the proposed study, we will conduct an observational study on PLWH with COVID-19, collecting patients’ characteristics, outcomes, and determining the predictors associated with outcomes at the two major teaching hospitals in the District of Columbia.